Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05221606 · ClinicalTrials.gov registry record · NA
Nurse AMIE (Addressing Malignancies in Individuals Everyday)
A NA study of Cancer, sponsored by University of Pittsburgh.
- Active
- Registry status
- NA
- Development phase
- 344
- Enrollment target
- 8
- Study locations
NCT05221606: Active NA study of Cancer, sponsored by University of Pittsburgh.
NCT05221606 is a NA study of Cancer that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 344 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (90% lower). The trial reports 8 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05221606, a NA study of Cancer, is active but no longer recruiting, sponsored by University of Pittsburgh.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 344 participants
- Enrollment target
- 8
- Study locations
Study Summary
Nurse AMIE 3.0 is testing the effectiveness of an electronic symptom management system on overall survival in people with stage 3 and 4 cancer who live in rural areas.
Primary Outcome
Survival of each participant will be monitored through the electronic medical records throughout the course of the study. After the study is completed, we will monitor survival using the National Death Index from the Centers for Disease Control and Prevention (CDC).
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Nurse AMIE
Study Locations (8)
Pennsylvania
- UPMC-Butler - Butler
- UPMC - Greenville - Greenville
- Penn State Hershey Medical Center - Hershey
- UPMC - Indiana - Indiana
- UPMC - New Castle - New Castle
- UPMC - Northwest - Seneca
- Mount Nittany Medical Center - State College
West Virginia
- West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 344 participants |
| Start Date | 2022-05-03 |
| Est. Completion | 2027-03 |
| Phase | NA |
What the registry record for NCT05221606 still lists
NCT05221606 is an interventional study that assigns participants to a tested intervention. The registered 344 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT05221606 lists 8 locations in 2 states (Pennsylvania, West Virginia).
Frequently Asked Questions
What is clinical trial NCT05221606 about?
NCT05221606 is a clinical study titled "Nurse AMIE (Addressing Malignancies in Individuals Everyday)". Nurse AMIE 3.0 is testing the effectiveness of an electronic symptom management system on overall survival in people with stage 3 and 4 cancer who live in rural areas.
What is the current status of trial NCT05221606?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 344 participants. The study started on 2022-05-03. Estimated completion is 2027-03.
What conditions does trial NCT05221606 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT05221606?
The interventions under investigation include: Usual Care (BEHAVIORAL), Nurse AMIE (BEHAVIORAL).
Who is sponsoring clinical trial NCT05221606?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05221606 being conducted?
This trial has 8 study locations across Pennsylvania, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05221606's enrollment target sits among peer trials
344 168th of 615 higher than 448 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06733363 · 344 participants · Phase 2
A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
- NCT07179380 · 344 participants · Phase 3
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- NCT07304024 · 344 participants · Phase 1
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
- NCT03972657 · 345 participants · Phase 1
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI